Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized maintenance Azacitidine in elderly AML and RAEB/RAEB-t
2008-001290-15Phase 3Completed
- Sponsor
- HOVON
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute myeloid leukemia (AML), myelodysplastic syndrome with excess blasts (MDS-EB) and refractory anemia with excess blasts in transformation (RAEB-T) comparing Azacitidine maintenance with Observation (2 arms). Primary endpoint: Disease-free survival. Started Dec 2008; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome with excess blasts (MDS-EB)refractory anemia with excess blasts in transformation (RAEB-T)
Beyond the preview
Go deeper on 2008-001290-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001290-15.